These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19542314)

  • 1. Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations.
    Tyl B; Kabbaj M; Fassi B; De Jode P; Wheeler W
    J Clin Pharmacol; 2009 Aug; 49(8):905-15. PubMed ID: 19542314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects.
    Sarapa N; Gussak I; Vajdic B; George S; Hadzievski L; Francom SF; Kowey P
    J Electrocardiol; 2009; 42(4):358-66. PubMed ID: 19362316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the precision of QT measurements.
    Darpo B; Fossa AA; Couderc JP; Zhou M; Schreyer A; Ticktin M; Zapesochny A
    Cardiol J; 2011; 18(4):401-10. PubMed ID: 21769821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of manual and automated measurements of the QT interval in healthy volunteers: an analysis of five thorough QT studies.
    Fosser C; Duczynski G; Agin M; Wicker P; Darpo B
    Clin Pharmacol Ther; 2009 Nov; 86(5):503-6. PubMed ID: 19339965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Man versus machine: is there an optimal method for QT measurements in thorough QT studies?
    Darpo B; Agin M; Kazierad DJ; Layton G; Muirhead G; Gray P; Jorkasky DK
    J Clin Pharmacol; 2006 Jun; 46(6):598-612. PubMed ID: 16707406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A thorough QTc study to assess the effect of sitagliptin, a DPP4 inhibitor, on ventricular repolarization in healthy subjects.
    Bloomfield DM; Krishna R; Hreniuk D; Hickey L; Ghosh K; Bergman AJ; Miller J; Gutierrez MJ; Stoltz R; Gottesdiener KM; Herman GA; Wagner JA
    J Clin Pharmacol; 2009 Aug; 49(8):937-46. PubMed ID: 19602719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semiautomated QT interval measurement in electrocardiograms from a thorough QT study: comparison of the grouped and ungrouped superimposed median beat methods.
    Hingorani P; Karnad DR; Ramasamy A; Panicker GK; Salvi V; Bhoir H; Kothari S
    J Electrocardiol; 2012; 45(3):225-30. PubMed ID: 22364647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval.
    Iwamoto M; Kost JT; Mistry GC; Wenning LA; Breidinger SA; Marbury TC; Stone JA; Gottesdiener KM; Bloomfield DM; Wagner JA
    J Clin Pharmacol; 2008 Jun; 48(6):726-33. PubMed ID: 18441333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
    Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
    Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the sensitivity of detecting drug-induced QTc changes using subject-specific rate correction.
    Cassani González R; Engels EB; Dubé B; Nadeau R; Vinet A; LeBlanc AR; Sturmer M; Becker G; Kus T; Jacquemet V
    J Electrocardiol; 2012; 45(6):541-5. PubMed ID: 22960165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study.
    Zhang L; Chappell J; Gonzales CR; Small D; Knadler MP; Callaghan JT; Francis JL; Desaiah D; Leibowitz M; Ereshefsky L; Hoelscher D; Leese PT; Derby M
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):146-53. PubMed ID: 17414226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thorough QT study with recommended and supratherapeutic doses of tolterodine.
    Malhotra BK; Glue P; Sweeney K; Anziano R; Mancuso J; Wicker P
    Clin Pharmacol Ther; 2007 Mar; 81(3):377-85. PubMed ID: 17339867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic comparisons of electrocardiographic morphology increase the precision of QT interval measurement.
    Hnatkova K; Smetana P; Toman O; Bauer A; Schmidt G; Malik M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):119-30. PubMed ID: 19140922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single therapeutic and supratherapeutic doses of laropiprant, a selective prostaglandin D2 receptor 1 antagonist, do not prolong the QTcF interval in healthy volunteers.
    Luo WL; Crumley T; Ebel D; Atiee GJ; Royalty J; Johnson-Levonas AO; Wagner J; Lai E
    J Clin Pharmacol; 2010 Nov; 50(11):1273-9. PubMed ID: 20107202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized extraction of electrocardiograms from continuous 12-lead holter recordings reduces measurement variability in a thorough QT study.
    George S; Rodriguez I; Ipe D; Sager PT; Gussak I; Vajdic B
    J Clin Pharmacol; 2012 Dec; 52(12):1891-900. PubMed ID: 22187440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Period correction of the QTc of moxifloxacin with multiple predose baseline ECGs is the least variable of 4 methods tested.
    Zhang X; Silkey M; Schumacher M; Wang L; Raval H; Caulfield JP
    J Clin Pharmacol; 2009 May; 49(5):534-9. PubMed ID: 19287043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of number of replicate electrocardiograms recorded at each time point in a thorough QT study on sample size and study cost.
    Natekar M; Hingorani P; Gupta P; Karnad DR; Kothari S; de Vries M; Zumbrunnen T; Narula D
    J Clin Pharmacol; 2011 Jun; 51(6):908-14. PubMed ID: 20852005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies.
    Sarapa N; Nickens DJ; Raber SR; Reynolds RR; Amantea MA
    Clin Pharmacol Ther; 2008 Jan; 83(1):153-9. PubMed ID: 17581594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the human QT interval: novel distribution-based assessment of the repolarization effects of moxifloxacin.
    Holzgrefe HH; Ferber G; Morrison R; Meyer O; Greiter-Wilke A; Singer T
    J Clin Pharmacol; 2012 Aug; 52(8):1222-39. PubMed ID: 21659628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of clinically significant QTc prolongation in phase I studies in healthy participants: comparison of 2 semiautomated QT measurement methods.
    Sarapa N; Francom SF; Azzam SM; Wickremasingha PK; Tyl B
    J Clin Pharmacol; 2009 Jan; 49(1):103-8. PubMed ID: 18957527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.